Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

2009 influenza A(H1N1) monovalent vaccines for children.

Fiore AE, Neuzil KM.

JAMA. 2010 Jan 6;303(1):73-4. doi: 10.1001/jama.2009.1929. Epub 2009 Dec 21. No abstract available.

PMID:
20026596
2.

Update on influenza A (H1N1) 2009 monovalent vaccines.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Oct 9;58(39):1100-1.

3.

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62. Erratum in: MMWR Recomm Rep. 2010 Aug 13;59(31):993. MMWR Recomm Rep. 2010 Sep 10;59(35):1147.

4.

Pandemic influenza. Europe reconsiders H1N1 flu shots for children.

Enserink M.

Science. 2009 Nov 13;326(5955):922. doi: 10.1126/science.326.5955.922. No abstract available.

PMID:
19965485
5.

Insurers prepare for 2nd wave of H1N1 flu.

Berberabe T.

Manag Care. 2009 Sep;18(9):55-6. No abstract available.

6.

Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.

Salmon DA, Akhtar A, Mergler MJ, Vannice KS, Izurieta H, Ball R, Lee GM, Vellozzi C, Garman P, Cunningham F, Gellin B, Koh H, Lurie N; H1N1 Working Group of Federal Immunization Safety Task Force.

Pediatrics. 2011 May;127 Suppl 1:S78-86. doi: 10.1542/peds.2010-1722L. Epub 2011 Apr 18. Review.

PMID:
21502251
7.

Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.

Lu CY, Shao PL, Chang LY, Huang YC, Chiu CH, Hsieh YC, Lin TY, Huang LM.

Vaccine. 2010 Aug 16;28(36):5864-70. doi: 10.1016/j.vaccine.2010.06.059. Epub 2010 Jul 13.

PMID:
20600484
8.

A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign.

Dubé E, Fannie D, Vladimir G, Julie BA, Chantal S, France L, François BD, Shelly M, Ian G, Nicole B.

BMC Public Health. 2011 Feb 22;11:128. doi: 10.1186/1471-2458-11-128.

9.

Public health. Who should get influenza vaccine when not all can?

Emanuel EJ, Wertheimer A.

Science. 2006 May 12;312(5775):854-5. No abstract available.

PMID:
16690847
10.

Mark Mulligan leads Emory swine flu vaccine trial. Interview by Brooke Grindlinger.

Mulligan M.

J Clin Invest. 2009 Sep;119(9):2438. No abstract available.

11.

Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age.

Waddington C, Andrews N, Hoschler K, Walker W, Oeser C, Reiner A, John T, Wilkins S, Casey M, Eccleston P, Allen R, Okike I, Ladhani S, Sheasby E, Waight P, Collinson A, Heath P, Finn A, Faust S, Snape M, Miller E, Pollard A.

Health Technol Assess. 2010 Oct;14(46):1-130. doi: 10.3310/hta14460-01.

12.

Pandemic influenza vaccine policy--considering the early evidence.

Neuzil KM.

N Engl J Med. 2009 Dec 17;361(25):e59. doi: 10.1056/NEJMe0908224. Epub 2009 Sep 10. No abstract available.

13.
14.

Swine flu outbreak. China first to vaccinate against novel H1N1 virus.

Stone R.

Science. 2009 Sep 18;325(5947):1482-3. doi: 10.1126/science.325_1482. No abstract available.

PMID:
19762610
15.

Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1).

Barrett PN, Ehrlich HJ.

Lancet Infect Dis. 2011 Jul;11(7):496-7; author reply 497-8. doi: 10.1016/S1473-3099(11)70155-4. No abstract available.

PMID:
21700237
17.

Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Dec 11;58(48):1351-6.

18.

Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2009 Aug 28;58(RR-10):1-8.

19.

The 2009 Swine-Origin Influenza A (H1N1) Epidemic.

Wood BP.

AJR Am J Roentgenol. 2010 Feb;194(2):294-5. doi: 10.2214/AJR.09.3864. No abstract available.

PMID:
20093585
20.

Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children.

Meier S, Bel M, L'huillier A, Crisinel PA, Combescure C, Kaiser L, Grillet S, Pósfay-Barbe K, Siegrist CA; H1N1 Epidemiology Study Group of Geneva.

Vaccine. 2011 Apr 27;29(19):3548-57. doi: 10.1016/j.vaccine.2011.02.094. Epub 2011 Mar 17.

Items per page

Supplemental Content

Write to the Help Desk